Samsara BioCapital as of Sept. 30, 2019
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 18 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals In | 18.2 | $27M | 404k | 66.36 | |
| Allakos | 15.4 | $23M | 287k | 78.63 | |
| Syros Pharmaceuticals | 11.6 | $17M | 1.7M | 9.85 | |
| Springworks Therapeutics (SWTX) | 10.0 | $15M | 677k | 21.68 | |
| Odonate Therapeutics Ord | 9.3 | $14M | 523k | 26.03 | |
| Principia Biopharma | 7.4 | $11M | 384k | 28.24 | |
| Sutro Biopharma | 7.0 | $10M | 1.1M | 9.09 | |
| Atreca Inc Cl A (BCEL) | 4.9 | $7.2M | 591k | 12.24 | |
| Gossamer Bio (GOSS) | 4.3 | $6.3M | 377k | 16.79 | |
| Hookipa Pharma Inc equity | 2.7 | $4.0M | 530k | 7.50 | |
| Aravive | 2.3 | $3.3M | 443k | 7.50 | |
| Sunesis Pharmaceuticals Inc Ne | 1.8 | $2.6M | 3.6M | 0.72 | |
| Catabasis Pharmaceuticals Ord | 1.1 | $1.6M | 300k | 5.40 | |
| Urovant Sciences | 1.0 | $1.5M | 158k | 9.47 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $1.4M | 119k | 11.60 | |
| Evelo Biosciences | 0.9 | $1.4M | 228k | 6.10 | |
| Millendo Therapeutics | 0.9 | $1.3M | 187k | 7.11 | |
| Liquidia Technologies (LQDA) | 0.4 | $550k | 155k | 3.56 |
